Aimee C Colbath

6PUBLICATIONS
9CO-AUTHORS
Haematological tumoursToxicology (incl. clinical toxicology)Regenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 16, 2024
Clodronate disodium does not produce measurable effects on bone metabolism in an exercising, juvenile, large animal model.

Fernando B Vergara-Hernandez, Brian D Nielsen, John M Popovich

|Oct 26, 2023
Effects of phenylbutazone, firocoxib, and dipyrone on the diuretic response to furosemide in horses.

Julianne M White, Aimee C Colbath, Harold C Schott

|Oct 11, 2022
Clodronate disodium is neither cytotoxic nor cytoprotective to normal and recombinant equine interleukin-1β-treated joint tissues in vitro.

Fernando B Vergara-Hernandez, Char L Panek, Brian D Nielsen

|Jan 24, 2020
Mesenchymal stem cells for treatment of musculoskeletal disease in horses: Relative merits of allogeneic versus autologous stem cells.

Aimée C Colbath, Steven W Dow, C Wayne McIlwraith

|Dec 11, 2019
Single and repeated intra-articular injections in the tarsocrural joint with allogeneic and autologous equine bone marrow-derived mesenchymal stem cells are safe, but did not reduce acute inflammation in an experimental interleukin-1β model of synovitis.

Aimée C Colbath, Steven W Dow, Leone S Hopkins

|May 24, 2019
Allogeneic vs. autologous intra-articular mesenchymal stem cell injection within normal horses: Clinical and cytological comparisons suggest safety.

A C Colbath, S W Dow, L S Hopkins

Pageof 1

Frequent Collaborators

2 joint publications

Fernando B Vergara-Hernandez

2 joint publications

Char L Panek

2 joint publications

Brian D Nielsen

2 joint publications

Cara I Robison